Parmax Pharma Limited (BSE: 540359)
Health Care · Pharmaceuticals · IN
Rs129.90
+10.32% today · +265.9% 1Y
Parmax Pharma Limited (BSE: 540359) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.08M.
Over the last twelve months the share price has gained 265.9%, trading between 22.60 and 129.90.
540359 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.08M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.06
- 52-week high
- Rs129.90
- 52-week low
- Rs22.60
- Avg volume (3M)
- —
- Shares outstanding
- 3.74M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.70 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.02 | -0.74% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.20 | +0.36% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.